ARTICLE | Distillery Techniques
Biomarkers
December 19, 2017 8:53 PM UTC
Oligodendrocytes expressing BCAS1 could help monitor responses to remyelinating therapies in MS and other demyelinating diseases. In postmortem brain tissue samples from subjects without demyelinating...
BCIQ Company Profiles
BCIQ Target Profiles